Seido Capital is an early and growth stage healthcare investor active in North America with 150 M$ AuM. Building on 20 years of top-quartile track record, we partner with visionary entrepreneurs to address critical challenges through groundbreaking innovation in biotechnology, medical devices and AI tools for the life sciences industry.

Seido Capital

Théo Risopoulos

This department focuses on evaluating investment opportunities and analyzing financial data to support strategic decision-making.

Seido Capital

Org chart

Teams

Investment Analysis

Offices